Skip to main content
    M

    Mustang Bio Inc (MBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    -0.00 (-0.96%)

    Market Cap: $3.20M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Mustang Bio Inc (MBIO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Mustang Bio (MBIO) has a market cap of $3.20M. It holds $14.28M more cash than debt, 446.70% of its market cap. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$3.20M
    Latest price (Nov 17, 2026)$0.39

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.04% in the quarter ended Sep 30, 2026.

    Shares Outstanding6.74M
    Shares Change (YoY)+7.92%
    Shares Change (QoQ)+0.04%

    Price Statistics

    The stock is down 67.96% over 52 weeks and trades 11.36% below its 50-day average.

    Beta (1Y)0.99
    52-Week Change-67.96%
    1-Month Change+4.80%
    3-Month Change-31.90%
    6-Month Change-39.10%
    5-Year Change-99.98%
    Total Return (1Y)-67.96%
    Total Return (3Y CAGR)-83.13%
    Total Return (5Y CAGR)-81.22%
    Max Drawdown (1Y)-74.50%
    Max Drawdown (3Y)-99.57%
    Sharpe Ratio (1Y)-1.73
    Correlation with SPY (1Y)0.20
    50-Day Average$0.44
    200-Day Average$0.65
    52-Week Range$0.35 to $1.43
    RSI (14 Days)44.7
    Average Volume (20 Days)35.61K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Returns and Efficiency

    Return on equity is -53.58% and return on assets is -24.03% over the last 12 months.

    Return on Equity (ROE)-53.58%
    Return on Assets (ROA)-24.03%
    ROIC (5Y Average)-20.16%

    Scores

    MBIO has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$3.96M
    Pretax Income-$3.53M
    Net Income-$3.53M
    Reported EPS (TTM)-$0.52

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 44.89% of the $14.68M in total assets.

    Cash and Equivalents$14.28M
    Total Debt$0
    Net Cash$14.28M
    Net Cash Per Share$2.12
    Working Capital-$7.95M
    Shareholder Equity$6.59M
    Book Value Per Share$0.98
    Total Assets$14.68M
    Total Liabilities$8.10M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$4.57M
    FCF Per Share-$0.68

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    MBIO does not pay a dividend.

    Buyback Yield5.28%
    Shareholder Yield5.28%

    Stock Splits

    The last split was a 1-for-50 reverse split on Jan 16, 2025.

    Last Split DateJan 16, 2025
    Split TypeReverse split
    Split Ratio1:50

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About MBIO

    What is MBIO's market cap?

    Mustang Bio has a market cap of $3.20M.

    How many shares of MBIO are outstanding?

    Mustang Bio has 6.74M shares outstanding. The count is up 7.92% from a year earlier.

    Does MBIO pay a dividend?

    No. Mustang Bio does not pay a dividend.

    How much debt does MBIO have?

    Mustang Bio has $0 of total debt and $14.28M of cash and equivalents, a net cash position of $14.28M.